You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
DC Vaccination in CML
Recruiting
  • Myeloid Leukemia, Chronic
  • DC vaccine
  • Berlin, Germany
  • +1 more
2021-08-03
Aug 3, 2021
G
Myeloid Mutations Register in R/R CML
Recruiting
  • Chronic Myeloid Leukaemia Recurrent
  • Chronic Myeloid Leukemia, in Relapse
  • Myeloid mutations measurement
  • Huixquilucan, Estado De México, Mexico
    Grupo Cooperativo de Hemopatías Malignas
2021-10-04
Oct 4, 2021
N
Flumatinib Efficacy and Safety for New Diagnosed Chronic Phase Chronic Myeloid Leukemia
Recruiting
  • Validity and Safety
    • Guangzhou, Guangdong, China
      NanfangH
    2021-09-02
    Sep 2, 2021
    M
    Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment - 2021
    Completed
    • Chronic Myelogenous Leukemia, BCR-ABL Positive
    • CML, Chronic Phase
    • Pioglitazone 15mg
    • Mansoura, Dakahlia, Egypt
      Faculty of Medicine
    2021-05-11
    May 11, 2021
    M
    ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase
    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-12-29
    Dec 29, 2021
    S
    Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP
    Recruiting
    • Dasatinib
    • +2 more
    • Shenzhen, Guangdong, China
      Xin Du
    2021-06-09
    Jun 9, 2021
    A
    TIGIT in Patients With Chronic Myeloid Leukemia
    Not yet recruiting
    • Chronic Myeloid Leukemia
    • flow cytometry test
    • (no location specified)
    2021-03-25
    Mar 25, 2021
    I
    Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Beijing, China
      Peking University People's Hospital(北京大学人民医院)
    2022-01-03
    Jan 3, 2022
    A
    FLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor（TKI）Stopping in Chronic Myeloid Leukemia
    Recruiting
    • Folate
    • +2 more
      • Nantong, China
        Affliated Hospital of Nantong University
      2021-12-13
      Dec 13, 2021
      M
      Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia
      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      2021-05-07
      May 7, 2021
      U
      Italian Treatment Free Remission Registry
      Recruiting
      • Treatment Free Remission
      • Chronic Myeloid Leukemia
        • Turin, Italy
          Division of Hematology-AO Mauriziano Hospital, University of Tur
        2021-11-17
        Nov 17, 2021
        L
        IIT PH1 KDS-1001 in Patients With CML
        Not yet recruiting
        • CML (Chronic Myelogenous Leukemia
        • (no location specified)
        2021-11-29
        Nov 29, 2021
        U
        Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose
        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
          • Jena, Germany
            University Hospital Jena
          2021-08-12
          Aug 12, 2021
          P
          Safety And Efficacy Of Bosutinib
          Recruiting
          • Chronic Myelogenous Leukemia
          • Shibuya-ku, Japan
            (unnamed)
          2020-12-29
          Dec 29, 2020
          H
          Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention - 2021
          Completed
          Has Results
          • Chronic Myelogenous Leukemia
          • Therapy for Targeted Therapy-related Fatigue (TTF)
          • Wait-List Control Condition (WLC)
          • Tampa, Florida
            H. Lee Moffitt Cancer Center and Research Institute
          2021-11-15
          Nov 15, 2021
          P
          Innate T Cells and TKI Discontinuation
          Not yet recruiting
          • Chronic Myeloid Leukemia
          • Characteristics of innate T cells
          • (no location specified)
          2020-11-25
          Nov 25, 2020
          W
          Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy - 2021
          Completed
          • Chronic Myeloid Leukemia
          • New York, New York
            Weill Cornell Medical College
          2022-01-04
          Jan 4, 2022
          x
          A Study for PRO of CML in Real Word
          Recruiting
          • CML (Chronic Myelogenous Leukemia)
          • questionnaire
          • Guanzhou, China
            Department of Hematology, Nanfang Hospital, Southern Medical Uni
          2021-10-11
          Oct 11, 2021
          M
          Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
          Recruiting
          • Chronic Myelogenous Leukemia
          • Chart Review
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          2021-11-24
          Nov 24, 2021
          M
          Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia - 2021
          Terminated
          • Chronic Myeloid Leukemia, Chronic Phase
          • Eicosapentaenoic Acid
          • Tyrosine kinase inhibitor
          • Hershey, Pennsylvania
            Penn State Cancer Institute
          2021-10-04
          Oct 4, 2021
          A
          Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
          Recruiting
          • Chronic Myelogenous Leukemia
          • Beirut, Lebanon
            American University of Beirut Medical Center
          2021-01-11
          Jan 11, 2021
          W
          Evaluating Efficacy and Safety of Flumatinib Versus Nilotinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib
          Recruiting
          • CML-CP; Mutation;Suboptimal Response or Failure in TKI
          • Wuhan, Hubei, China
            Weiming Li
          2021-05-31
          May 31, 2021
          H
          Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt - 2020
          Completed
          • Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
          • Cairo, Egypt
            National Cancer Institute (NCI)
          2021-02-22
          Feb 22, 2021
          A
          Effect of Pharmacogenetics on Imatinib Plasma Level and Response
          Active, not recruiting
          • Chronic Myeloid Leukemia
          • PCR
          • HPLC-UV
          • Assiut, Egypt
            South Egypt Cancer Institute
          2021-08-01
          Aug 1, 2021
          U
          Myeloproliferative Neoplasms (MPNs) Patient Registry
          Recruiting
          • Primary Myelofibrosis
          • +9 more
          • Observational
          • Toronto, Ontario, Canada
            Princess Margaret Cancer Centre
          2021-04-01
          Apr 1, 2021